熱門資訊> 正文
Vista Healthcare业务报告导致Chemed股价下跌
2026-08-28 02:33
- Chemed (CHE) fell 4.6% amid a report about the company's Vista Healthcare business.
- The report was published by the Capitol Forum, according to a post on X on Thursday.
- Chemed (CHE) didn't immediately respond to a Seeking Alpha request for comment.
- Chemed, which is the target of activist investor Barington Capital, has short interest of 3.5%. Barington last month said it wants the hospice service and Roto-Rooter owner to start a strategic review and change its board.
More on Chemed
- Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value
- Chemed Corporation (CHE) Q2 2026 Earnings Call Transcript
- Chemed Corporation 2026 Q2 - Results - Earnings Call Presentation
- Chemed forecasts 2026 EPS of $25-$25.75 as VITAS targets 5.75%-6.25% ADC growth
- Chemed Q2 2026 Earnings Preview
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
